Gan & Lee Pharmaceuticals (hereinafter referred to as Gan & Lee, SSE: 603087) announced the signing of an exclusive licensing ...
BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
The strongest human data on psychedelic and cannabis co-use comes from a 2022 prospective survey study by Kuc et al.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results